Assistant-level or higher professor with cancer-relevant work in the last 3 years.

1. Publications: Authorship of peer-reviewed cancer-relevant publications
   
2. Grants: Obtained or received substantial effort from extramural cancer-relevant peer-reviewed grant support (as PI, MPI, co-PI, co-Investigator)
3. Clinical Research Studies: Played an integral role in clinical research studies*, through protocol development, implementation, patient accrual, etc. *Includes patient-oriented research, epidemiological and behavioral studies, and health services research.

Alternatively, obtained membership at the Consortium director's discretion. For example, if individual provides specialized medical, scientific, or administrative expertise to the Consortium's overall research mission.

• Invitations to research program retreats and Consortium-wide symposia
• Subsidized rates on Consortium Shared Resources
• Eligibility to apply for Cancer Center Support Grant (CCSG) Developmental Funds, CCSG Administrative Supplement Funds and other Consortium philanthropic funds
• Access to Consortium Clinical Research Support services and Institutional Review Board (IRB)
• Access to resources for community outreach and engagement as well as education and training

• Participate in programmatic activities, such as program retreats, as applicable
• Serve on Consortium committees, including Scientific Review Committees and Developmental Funds Review Committee, as applicable (based on area of expertise matching committee needs; anticipated cadence for service on a committee that meets monthly would be a 3-year term approximately every 10 years)
• Cite the Cancer Center Support Grant (CCSG) in all publications, press releases, or other documents that cite results from CCSG-supported research, including if resulting from the use of Shared Resources (must include acknowledgement of the grant and maintain compliance with the NIH Public Access Policy)
• Follow all clinical research policies as outlined by Clinical Research Support

Applications are accepted on a rolling basis and are typically processed within 7 business days. Formal acknowledgement of your membership will be provided once your application is approved.

Membership is reviewed regularly for eligibility, including institutional appointments and cancer-relevance of publications, grants, and clinical research studies. Members are notified of pending inactivation if they no longer appear eligible and have the opportunity to provide clarification through this process.

Provisional membership: Members are notified of pending inactivation if after 3 years they do not appear to have evidence of cancer-related work. If provisional members become eligible for membership during their 3-year provisional membership, they can request membership in a Consortium research program by contacting Consortium administration.